Arne Staby

Novo Nordisk (Denmark)

Papers

3

Total Citations

65

H-Index

3

About

Arne Staby is a bioprocess engineer and researcher whose work sits at the intersection of protein science and downstream bioprocessing, with a particular focus on developing innovative, scalable methods for biological product purification. His research has made meaningful contributions to the field of biopharmaceutical manufacturing, where efficient and cost-effective separation technologies are critical to bringing therapies from the laboratory to the clinic. Staby is perhaps best recognized for his work on high-throughput screening methodologies, including a widely cited 2009 study introducing a novel approach to evaluating protein solubility, which has garnered 28 citations and provided researchers with faster, more systematic tools for early-stage protein characterization. His subsequent investigations into aqueous two-phase systems (ATPS) for cell-based product purification, published in 2016, have collectively attracted nearly 40 citations and addressed a critical bottleneck in translating cell therapies toward clinical development. These studies demonstrated that ATPS offers a gentle, label-free, and scalable solution for cell purification — qualities essential for sensitive biological products. Through his emphasis on high-throughput, practical, and translatable downstream processing strategies, Staby's research supports the broader goal of making biopharmaceutical and cell-based therapies more accessible and manufacturable at scale.

Research Focus

Key Achievements

3
H-Index
3
Papers
65
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
A novel method to evaluate protein solubility using a high throughput screening approach
28 citations · 2009
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Novo Nordisk (Denmark)

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago